T here is little doubt that infectious diseases are the major challenge of medicine at the opening of this new century (1) . They are still by far the major population control factor of our species. At the very least, this peril of emerging and reemerging infectious diseases (2) has the beneficial side effect of boosting basic research. It is indeed a paradox that, for example, the basic biology of Mycobacterium tuberculosis, the causative agent of a major human disease, is far less well known than that of Escherichia coli, potentially because tuberculosis was more or less effectively controlled in the north. Facing the threat of tuberculosis epidemics throughout the world, scientists are currently erasing the somewhat artificial border between basic and applied research and are generating data that have both a strong added value in terms of basic science and an immediate usefulness for epidemiology and medicine. The two companion papers by Tsolaki et al. (3) and Hirsh et al. (4) in this issue of PNAS are perfect examples of this new scientific school, as well as of the opportunities offered by the progress of modern biotechnology when they are wisely used.
Like many organisms, the whole genome of M. tuberculosis has now been entirely sequenced (5) . In itself, this is a major technological achievement that carried with it a great deal of raw material and crude data. The analysis of this bacterium's genome sequence has itself led to informative hypotheses on its biology (6) . However, because only one reference strain (H37Rv) was originally sequenced (5), information on the species' genetic variability was lacking. Using this sequence and the powerful technology of microarrays, Tsolaki, Hirsh, and colleagues (3, 4) built a highly resolvent tool of comparative genomics to explore the genetic diversity of 100 M. tuberculosis isolates from tuberculosis patients in San Francisco. This subsample had been taken from a broader sample of 1,802 isolates collected in the same area between 1991 and 1999, which had been characterized by using two molecular methods: IS6110 and polymorphic G-C-rich sequence (PGRS). These well standardized typing tools are widely used by molecular epidemiologists working with M. tuberculosis. They are the basis for international electronic networks of researchers (7).
These two markers are not perfect tools in terms of phylogenetic analysis and population genetics, because their target molecules are very specific DNA sequences that are not representative of the entire genome, and because they do not permit the analysis of a large number of independent genetic loci (8). However, they give useful information on the epidemiological relationships among strains. In the two papers analyzed here (3, 4) , isolates exhibiting the same profile for both IS6110 and PGRS were considered as the same ''strain,'' related to clustered (epidemiologically linked) cases. The final sample of 100 isolates was composed of 50 clustered and 50 nonclustered isolates.
Large deletions are assumed to play a major role in the molecular evolution of M. tuberculosis (9) . The two companion papers used these deletions as markers to answer distinct, although complementary, questions. Tsolaki et al. (3) took the clear working hypothesis that these large sequence polymorphisms play a more important role than simple DNA base substitutions (single nucleotide polymorphisms) in the phenotypic expression of M. tuberculosis, including antibiotic resistance and pathogenicity. Through PCR amplification and sequencing of the regions that flank deletions, it was possible to map them to the base pair. Through statistical randomization procedures, the authors (3, 4) explored how far the localization of deletions departs from random expectations. They found two types of deletions: those that are limited to phylogenetically related isolates and those that are distributed throughout the species. Three deletions combined both types of distribution. Those deletions that are clusterspecific likely stem from a genetic event specific to this lineage, whereas widely distributed deletions reflect properties of the involved sequences that are general in the species.
The H37Rv reference strain was found to comprise slightly more than 4,000 genes (5) (3) postulate that this is the case for the agent of tuberculosis and explore the effects of the deletions on the epidemiology of the disease. They find that, generally, deletions have slight deleterious effects. By comparing different functional gene categories, they discovered that some categories were overrepresented in deleted genes. This was the case for those genes involved in intermediary metabolism, respiration, and cell wall production. It is surprising that genes with such a crucial activity are frequently deleted. The hypothesis proposed is that they produce antigens and therefore undergo the selective pressure of the host's immunological system. Isolates that harbor deletions for these genes therefore have a short-term selective advantage, because they are able to better escape the host's immune defenses. However, because these genes are indispensable in the long run, their functionality is then restored. Other deletions had obvious advantages. One enhanced the resistance to isoniazid, a major antituberculosis antibiotic. Others disrupted the genes that allow the bacillus to survive in environments with little oxygen. This last property enables the bacteria to remain in a latency phase, without symptoms. When the genes are disrupted, the disease produces more severe symptoms, including cough, which obviously favors the dissemination of the bacterium (only pulmonary clinical forms are highly contaminating These two works are major contributions to our knowledge of the evolution of M. tuberculosis and illustrate the power of new technologies in modern biology. The results and hypotheses they contain have obvious implications in terms of medical research as well, because they tell us much about the evolutionary strategies utilized by M. tuberculosis to resist antibiotics, disseminate, and infect different human populations. Apart from satisfying our legitimate desire for pure knowledge, this kind of good science builds the foundation for the antibiotics and vaccines of tomorrow. 
